<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0006042'>Increased apoptosis</z:mp> of hematopoietic progenitor cells has been implicated in the pathophysiology of cytopenias associated with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (MDSs), and inhibition by immunosuppression may account for the success of this treatment in some patients </plain></SENT>
<SENT sid="1" pm="."><plain>We examined bone marrow and peripheral blood of 25 patients with chromosomal abnormalities associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (<z:mp ids='MP_0004026'>monosomy</z:mp> 7, <z:mp ids='MP_0004027'>trisomy</z:mp> 8, and 5q-) for evidence of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>When fresh bone marrow was examined, the number of apoptotic and Fas-expressing CD34 cells was increased in patients with <z:mp ids='MP_0004027'>trisomy</z:mp> 8, but decreased in <z:mp ids='MP_0004026'>monosomy</z:mp> 7, as compared with healthy control donor marrow </plain></SENT>
<SENT sid="3" pm="."><plain>Fas expression was increased in the <z:mp ids='MP_0004027'>trisomy</z:mp> 8 cells and decreased in the <z:mp ids='MP_0004026'>monosomy</z:mp> 7 cells when compared with <z:mpath ids='MPATH_458'>normal</z:mpath> cells from the same patient </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0004027'>Trisomy</z:mp> 8 cells were more likely to express activated caspase-3 than were <z:mpath ids='MPATH_458'>normal</z:mpath> cells </plain></SENT>
<SENT sid="5" pm="."><plain>For bone marrow cells cultured with Fas <z:chebi fb="4" ids="48705">agonist</z:chebi> or Fas <z:chebi fb="68" ids="48706">antagonist</z:chebi>, the percentage of cells with <z:mp ids='MP_0004027'>trisomy</z:mp> 8 was significantly decreased in most cases after Fas receptor triggering and increased by Fas ligand (Fas-L) <z:chebi fb="68" ids="48706">antagonist</z:chebi> (P &lt; 0.01), suggesting increased Fas susceptibility of cells with <z:mp ids='MP_0004027'>trisomy</z:mp> 8 </plain></SENT>
<SENT sid="6" pm="."><plain>No such changes were seen in cultures of cells with 5q- or <z:mp ids='MP_0004026'>monosomy</z:mp> 7 </plain></SENT>
<SENT sid="7" pm="."><plain>Fas <z:chebi fb="68" ids="48706">antagonist</z:chebi> facilitated the expansion of cells with <z:mp ids='MP_0004027'>trisomy</z:mp> 8 only </plain></SENT>
<SENT sid="8" pm="."><plain>Cells with <z:mp ids='MP_0004027'>trisomy</z:mp> 8 appear to be more susceptible to Fas-mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>Clinical data demonstrating the responsiveness of some patients with <z:mp ids='MP_0004027'>trisomy</z:mp> 8 to anti-thymocyte globulin (ATG) and <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> (CsA) would favor an active role of the immune system in this syndrome </plain></SENT>
</text></document>